אפטיפיבאטיד טבע ® 2 מ"ג/מ"ל

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

EPTIFIBATIDE 2 MG/ML

Prieinama:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kodas:

B01AC16

Vaisto forma:

SOLUTION FOR INJECTION

Vartojimo būdas:

I.V

Pagaminta:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Farmakoterapinė grupė:

EPTIFIBATIDE

Terapinės indikacijos:

Eptifibatide Teva is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-Q-wave myocardial infarction. Eptifibatide is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. Eptifibatide is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (PTCA) balloon angioplasty directional atheretomy transluminal extraction catheter atherectomy rotational ablation angioplasty or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death myorardial infarction need for urgent intervention). Eptifibatide is intended for use with aspirin and heparin.

Leidimo data:

2012-06-01